2011
DOI: 10.1007/s11418-011-0576-0
|View full text |Cite
|
Sign up to set email alerts
|

Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

Abstract: Tanshinone IIA (Tan IIA), a natural product from herb Salvia miltiorrhiza Bunge, has potential anti-tumor activity. The aim of this study was to pinpoint the molecular mechanisms underlying Tan IIA-induced cancer cell apoptosis. Human hepatoma BEL-7402 cells treated with Tan IIA underwent assessment with MTT assay for cell viability, 10-day culture for colony formation, flow cytometry and fluorescence microscopy for apoptosis and cell cycle analysis. Changes in intracellular [Ca(2+)] and mitochondrial membrane… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(21 citation statements)
references
References 49 publications
0
21
0
Order By: Relevance
“…As one of the most extensively investigated tanshinones, TIIA’s anti-neoplastic activities have been reported in various cancer cells including prostate [132,133], breast [134–140], colon [141], lung [142–145], liver [146–154], stomach [155–159], pancreas [160], bile duct [161], kidney [162], ovary [163–165], cervix [166], nasopharynx [167,168], glioma [169], osteosarcoma [170] and leukemia [171–175], in a broad concentration range from sub-micromolar to high micromolar. Sub-apoptotic concentrations of TIIA could induce G 0 /G 1 , S or G 2 /M arrest depending upon the cancer cell types.…”
Section: Anti-cancer Activities Of Tanshinonesmentioning
confidence: 99%
See 1 more Smart Citation
“…As one of the most extensively investigated tanshinones, TIIA’s anti-neoplastic activities have been reported in various cancer cells including prostate [132,133], breast [134–140], colon [141], lung [142–145], liver [146–154], stomach [155–159], pancreas [160], bile duct [161], kidney [162], ovary [163–165], cervix [166], nasopharynx [167,168], glioma [169], osteosarcoma [170] and leukemia [171–175], in a broad concentration range from sub-micromolar to high micromolar. Sub-apoptotic concentrations of TIIA could induce G 0 /G 1 , S or G 2 /M arrest depending upon the cancer cell types.…”
Section: Anti-cancer Activities Of Tanshinonesmentioning
confidence: 99%
“…The induction of cell cycle arrest was associated with up-regulation of P53, P21 and P27, and down-regulation of cyclinD 1 , CDK2, CDK4, cdc25 and cdc2 [132,141,146,147,150,155,156,162]. Higher concentrations of TIIA could induce caspase-dependent apoptosis, which was generally associated with increases of P53, P21, Fas, TNF-α, Bax/Bcl-2 ratio, disruption of mitochondrial membrane potential (MMP), enhancement of cytochrome c release, decreases of survivin, Mcl-1 L , EGFR and LC3-II, and activation of caspase-8, caspase-9 and caspase-3, suggesting the involvements of both intrinsic (Bax/Bcl-2/MMP/cytochrome c release/caspase-9/caspase3) and extrinsic (Fas/TNF-α/caspase-8/caspase-3) apoptosis pathways [132137,141–143,146–151,155,162,163,169–171]. TIIA was reported to decrease ErbB-2/HER2/Neu in Colo205 colon cancer xenograft tumors in male severe combined immunodeficient (SCID) mice (20 mg/kg of TIIA in corn oil, oral gavage, once per day for 30 days) [141], but not in MCF-7 and MDA-MD-231 breast cancer xenograft tumors in female nude mice (30 mg/kg of TIIA in Tween 20:ethanol = 1:99, subcutaneous (s.c.) injection, four times per week for four weeks) [137].…”
Section: Anti-cancer Activities Of Tanshinonesmentioning
confidence: 99%
“…TSA is able to traverse the blood brain barrier although the brain content is limited to 30% of 5 the plasma concentration (Chen et al, 2007), and this could relate to its effects in reducing the volume of cerebral infarction and maintenance of neuronal function (Lam et al, 2003). TSA has been shown to have protective effects against focal cerebral ischemia/reperfusion (I/R) injury in animal models (Tang et al, 2010; and has been proposed as a potential therapeutic agent in heart disease, liver disease and cancer treatment (Dai et al, 2012). …”
Section: Introductionmentioning
confidence: 99%
“…In addition to the MT level affecting the redox status of cells (Maret 2011;Vašák and Meloni 2011;Torreggiani et al 2013), MT may be affecting cation levels, including Ca 2+ , which directly and indirectly can affect oxidative and ER stress (Dai et al 2012;Hu et al 2013) as well as immunity.…”
Section: Discussionmentioning
confidence: 99%